Yahoo
NYSEArca - Delayed Quote USD

State Street SPDR S&P Pharmaceuticals ETF (XPH)

58.49 +0.88 (+1.53%)
At close: May 1 at 4:00:00 PM EDT
59.08 +0.59 (+1.01%)
After hours: May 1 at 7:59:55 PM EDT
Trade XPH on Coinbase
Chart Range Bar
Loading chart for XPH
  • Previous Close 57.61
  • Open 58.35
  • Bid 58.50 x 160000
  • Ask 58.60 x 60000
  • Day's Range 57.94 - 58.74
  • 52 Week Range 38.95 - 59.46
  • Volume 92,692
  • Avg. Volume 70,409
  • Net Assets 307.87M
  • NAV 58.57
  • PE Ratio (TTM) 19.38
  • Yield 0.69%
  • YTD Daily Total Return 4.55%
  • Beta (5Y Monthly) 0.88
  • Expense Ratio (net) 0.35%

In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").

State Street Investment Management

Fund Family

Health

Fund Category

307.87M

Net Assets

2006-06-19

Inception Date

Performance Overview: XPH

View More

Trailing returns as of 5/1/2026. Category is Health.

YTD Return

XPH
4.55%
Category
3.99%

1-Year Return

XPH
46.18%
Category
18.75%

3-Year Return

XPH
12.69%
Category
7.01%

People Also Watch

Holdings: XPH

View More

Top 10 Holdings (20.91% of Total Assets)

Symbol Company % Assets
ELVN 2.45%
CORT 2.29%
TERN 2.16%
PRGO 2.10%
AXSM 2.03%
INVA 1.99%
MRK 1.98%
PFE 1.97%
RPRX 1.97%
ELAN 1.96%

Sector Weightings

Research Reports: XPH

View More
  • Daily – Vickers Top Buyers & Sellers for 12/30/2025

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • Verisign to Continue to Benefit as Operator of Some of the Internet’s Most Valuable Real Estate

    Verisign is an operator of critical infrastructure within the domain name system, or DNS. As the registry for some of the world’s most popular TLDs, .com and .net, Verisign directs DNS resolvers to the appropriate registry where IP addresses are stored. Verisign’s control over its TLDs is regulated by ICANN and the NTIA and are subject to contract renewal every six years. The company generates revenue through annual subscriptions allowing customers to use .com and .net as their TLD of choice for their respective websites.

    Rating
    Price Target
  • Vornado Realty Trust: Dropping Coverage

    Vornado owns and has an ownership interest in Class A office and retail properties highly concentrated in Manhattan, with additional properties in San Francisco and Chicago. It operates as a real estate investment trust.

    Rating
    Price Target
  • Kenvue: Takeover by Kimberly-Clark Gives Shareholders a Lifeline

    Kenvue is the world’s largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson’s consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women’s health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson’s, Aveeno, and Neutrogena. Kenvue announced November 2025 that it signed a deal to be fully acquired by Kimberly-Clark with the deal expected to close during the second half of 2026.

    Rating
    Price Target

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: